fda advisory committee training an industry representative perspective alison lawton sr. vp...
TRANSCRIPT
FDA Advisory Committee Training
An Industry Representative Perspective
Alison Lawton
Sr. VP Regulatory Affairs
Genzyme Corporation
Background to Industry Representative
Introduced in FDA Modernization ActNon-voting member, non–SGE
– Financial interest disclosure
Conflict of interest?– Personal example
Process for Nomination
Federal Register notice publishedIndustry organizations interested send a
letter within 30 daysFDA requests organizations to consult in
selecting candidate (if more than 1 identified)
Single nominee provided to FDA within 60 days
How is the Industry Rep. Selected?
Industry Associations poll members for nominees
Nominees are reviewed by appropriate committee e.g. PhRMA RACC– Education, knowledge in subject, industry
experienceIndustry Associations agree on a single
nominee Nominee details sent to FDA
What is the role of the Industry Rep.?
Represents global concerns for industry (not their own company)
Provide industry perspective to discussions e.g. cost or practical application of a proposal, regulatory standards
Speak with industry &/or sponsor before meeting to ensure appropriate representation